- Report
- March 2026
- 83 Pages
Global
From €1131EUR$1,312USD£950GBP
- Report
- November 2025
- 400 Pages
Global
From €3567EUR$3,995USD£3,100GBP
- Report
- November 2025
- 300 Pages
Global
From €3567EUR$3,995USD£3,100GBP
- Report
- January 2026
- 314 Pages
Global
From €5181EUR$6,006USD£4,350GBP
- Report
- December 2025
- 341 Pages
Global
From €4285EUR$4,799USD£3,724GBP
- Report
- October 2025
- 86 Pages
Global
From €4285EUR$4,799USD£3,724GBP
- Report
- September 2025
- 450 Pages
Global
From €4420EUR$4,950USD£3,841GBP
- Report
- April 2025
- 387 Pages
Global
From €4018EUR$4,500USD£3,492GBP
- Report
- August 2025
- 165 Pages
Global
From €2009EUR$2,250USD£1,746GBP
- Report
- March 2026
- 269 Pages
Global
From €5223EUR$5,850USD£4,539GBP
- Report
- February 2026
- 250 Pages
Global
From €4009EUR$4,490USD£3,484GBP
- Report
- January 2026
- 150 Pages
Global
From €5313EUR$5,950USD£4,617GBP
- Report
- April 2025
- 110 Pages
Global
From €5313EUR$5,950USD£4,617GBP
- Report
- January 2026
- 186 Pages
Global
From €3165EUR$3,545USD£2,751GBP
€3517EUR$3,939USD£3,056GBP
- Report
- January 2026
- 182 Pages
Global
From €3165EUR$3,545USD£2,751GBP
€3517EUR$3,939USD£3,056GBP
- Report
- January 2026
- 184 Pages
Global
From €3165EUR$3,545USD£2,751GBP
€3517EUR$3,939USD£3,056GBP
- Report
- January 2026
- 185 Pages
Global
From €3165EUR$3,545USD£2,751GBP
€3517EUR$3,939USD£3,056GBP
- Report
- January 2026
- 187 Pages
Global
From €3165EUR$3,545USD£2,751GBP
€3517EUR$3,939USD£3,056GBP
- Report
- January 2026
- 199 Pages
Global
From €3165EUR$3,545USD£2,751GBP
€3517EUR$3,939USD£3,056GBP
- Report
- January 2026
- 197 Pages
Global
From €3165EUR$3,545USD£2,751GBP
€3517EUR$3,939USD£3,056GBP

The Vaccine Manufacturing market is a subset of the biopharmaceutical industry, which focuses on the development and production of vaccines. Vaccines are biological products that are used to prevent and treat infectious diseases. Vaccine manufacturing involves the production of active ingredients, such as antigens, as well as the formulation and packaging of the final product. Vaccine manufacturers must adhere to strict regulatory standards to ensure the safety and efficacy of their products.
The Vaccine Manufacturing market is highly competitive, with a number of large pharmaceutical companies and biotechnology firms competing for market share. Companies in the market include Merck & Co., GlaxoSmithKline, Sanofi, Pfizer, Johnson & Johnson, and Novavax. Show Less Read more